Sarcoidosis and its ocular manifestations

International Ophthalmology Clinics

Volumn 36, Issue 1, 1996, Pages 109-125

  Smith, Jill A ^b   Foster, C Stephen ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; CYCLOPLEGIC AGENT; CYTOTOXIC AGENT; DIFLUNISAL; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYPHENBUTAZONE; PREDNISONE; THYMOPENTIN;

BIOPSY; BONE LESION; BRAIN DISEASE; CATARACT; DRY EYE; EYE DISEASE; GLAUCOMA; HEART DISEASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRALESIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IRIDOCYCLITIS; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; LUNG SCINTISCANNING; ORAL DRUG ADMINISTRATION; ORBIT DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SARCOIDOSIS; THORAX RADIOGRAPHY; TOPICAL DRUG ADMINISTRATION;

EYE DISEASES; HUMANS; PROGNOSIS; SARCOIDOSIS;

EID: 0029921586     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-199603610-00012     Document Type: Review

References (77)

1. Hunter DG, Foster CS. Systemic manifestations of sarcoidosis. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology. Philadelphia: Saunders, 1994:3132-3142
2. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;135:747-760
3. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis - a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305:429-434
4. James DG, Graham E, Hamblin A. Immunology of multisystem ocular disease. Surv Ophthalmol 1985;30:155-167
5. Johns CJ, Scott PP, Schonfeld SA. Sarcoidosis. Annu Rev Med 1989;40:353-371
6. Jakobiec F, Jones I. Orbital inflammations. In: Jakobiec F, Jones I, eds. Diseases of the orbit. Hagerstown, MD: Harper & Row, 1979:187-261
7. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev 1983;5: 124-156
8. Hosoda Y. Epidemiology of sarcoidosis: state of the art. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders: Proceedings of the Eleventh World Congress. New York: Excerpta Medica, 1988:279-290
9. Slitzbach LE, James DG, Neville E, et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974;57:847-852
10. Hunter DG, Foster CS. Ocular manifestations of sarcoidosis. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology. Philadelphia: Saunders, 1994:443-450
11. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986;102:297-301
12. Rothova A, Alberts C, Glasius E, et al. Risk factors for ocular sarcoidosis. Doc Ophthalmol 1989;72:287-296
13. Mader TH, Chismire KJ, Cornell FM. The treatment of an enlarged sarcoid iris nodule with injectable corticosteroids. Am J Ophthalmol 1988;106:365-366
14. Geggel HS, Mensher JH. Cicatricial conjunctivitis in sarcoidosis: recognition and treatment. Ann Ophthalmol 1989;21:92-94
15. Tuft SJ, Watson PG. Progression of scleral disease. Ophthalmology 1991;98: 467-471
16. Fiore P. Inflammatory glaucoma. In: Albert DM, Jakobiec FA, eds. Principles and practice of ophthalmology. Philadelphia: Saunders, 1994:1426-1436
17. Haimovici R, Foster CS. Sarcoidosis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection and immunity. St Louis: Mosby, 1995 (in press)
18. Letocha CE, Shields JA, Goldberg RE. Retinal changes in sarcoidosis. Can J Ophthalmol 1975;10:184-192
19. Regan CD, Foster CS. Retinal vascular diseases: clinical presentation and diagnosis. Int Ophthalmol Clin 1986;26(2):25-53
20. Sanders MD, Shilling JS. Retinal, choroidal, and optic disc involvement in sarcoidosis. Trans Ophthalmol Soc UK 1976;96:140-144
21. Spalton DJ, Sanders MD. Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol 1981;65:348-358
22. Campo RV, Aaberg TM. Choroidal granuloma in sarcoidosis. Am J Ophthalmol 1984;97:419-427
23. Marcus DF, Bovino JA, Burton TC. Sarcoid granuloma of the choroid. Ophthalmology 1982;89:1326-1330
24. Tingey DP, Gonder JR. Ocular sarcoidosis presenting as a solitary choroidal mass. Can J Ophthalmol 1992;27:25-29
25. De-Potter P, Shields JA, Shields CL, et al. Unusual MRI findings in metastatic carcinoma to the choroid and optic nerve; a case report. Int Ophthalmol 1992;16: 39-44
26. Brod RD. Presumed sarcoid choroidopathy mimicking birdshot retinochoroidopathy. Am J Ophthalmol 1990;109:357-358
27. Kuboshiro T, Yoshioka H. Birdshot retinopathy - a possible relationship to ocular sarcoidosis. Kurume Med J 1988;35:193-199
28. Dick DJ, Newman PK, Richardson J, et al. Noncaseating conjunctival granulomas in patients with multifocal placoid pigment epitheliopathy and sarcoidosis. Br J Ophthalmol 1988;72:74-77
29. Hershey JM, Pulido JS, Massicotte SJ, et al. Noncaseating conjunctival granulomas in patients with multifocal choroiditis and panuveitis [abstract]. Invest Ophthalmol Vis Sci 1991;32:681
30. Graham EM, Edelsten C. Intermediate uveitis and sarcoidosis. Dev Ophthalmol 1992;23:106-110
31. Zierhut M, Foster CS. Multiple sclerosis, sarcoidosis, and other diseases in patients with pars planitis. Dev Ophthalmol 1992;23:41-47
32. Gass JDM, Olson CL. Sarcoidosis with optic nerve and retinal involvement. Arch Ophthalmol 1976;94:945-950
33. Duker JS, Brown GC, McNamara JA. Proliferative sarcoidosis retinopathy. Ophthalmology 1988;95:1680-1686
34. Gragoudas ES, Regan CDJ. Peripapillary subretinal neovascularization in presumed sarcoidosis. Arch Ophthalmol 1981;99:1194-1197
35. Kimmel AS, McCarthy MJ, Blodi CF, et al. Branch retinal vein occlusion in sarcoidosis. Am J Ophthalmol 1989;107:561-562
36. Steahly LP. Sarcoidosis and peripheral neovascularization. Ann Ophthalmol 1988; 20:426-427
37. Crick RP, Hoyle C, Smellie H. The eyes in sarcoidosis. Br J Ophthalmol 1961;45: 461-481
38. Karma A, Huhti E, Poukkula A. Course and outcome of ocular sarcoidosis. Am J Ophthalmol 1988;106:467-472
39. Harris GJ, Williams GA, Clarke GP. Sarcoidosis of the lacrimal sac. Arch Ophthalmol 1981;99:1198-1201
40. Imes RK, Reifchneider JS, O'Connor LE. Systemic sarcoidosis presenting initially with bilateral orbital and upper lid masses. Ann Ophthalmol 1988;20:466-469
41. Bersani TA, Nichols CW. Intralesional triamcinolone for cutaneous palpebral sarcoidosis. Am J Ophthalmol 1985;99:561-562
42. Brownstein S, Liszauer AD, Carey WD, Nicolle DA. Sarcoidosis of the eyelid skin. Can J Ophthalmol 1990;25:256-259
43. Collison JMT, Miller NR, Green WR. Involvement of orbital tissue by sarcoid. Am J Ophthalmol 1986;102:302-307
44. Khan JA, Hoover DL, Giangiacomo J, et al. Orbital and childhood sarcoidosis. J Pediatr Ophthalmol Strabismus 1983;23:190-194
45. Stannard K, Spalton DJ. Sarcoidosis with infiltration of the external ocular muscles. Br J Ophthalmol 1985;69:562-566
46. Sachs R, Kashii S, Burde RM. Sixth nerve palsy as the initial manifestation of sarcoidosis. Am J Ophthalmol 1990;110:438-440
47. Hoover DL, Khan JA, Giangiacomo J. Pediatric ocular sarcoidosis. Surv Ophthalmol 1986;30:215-228
48. Kalb RE, Epstein W, Grossman ME. Sarcoidosis with subcutaneous nodules. Am J Med 1988;85:731-736
49. Stern BJ, Krumholz A, John C, et al. Sarcoidosis and its neurological manifestations. Arch Neurol 1985;42:909-917
50. Rosenberg AM, Yee EH, MacKenzie JW. Arthritis in childhood sarcoidosis. J Rheumatol 1983;10:987-990
51. Lieberman J. Enzymes in sarcoidosis. Angiotensin converting enzyme (ACE). Clin Lab Med 1989;9:745-755
52. Studdy PR, Bird R. Serum angiotensin converting enzyme in sarcoidosis - its value in present clinical practice. Ann Clin Biochem 1989;26:13-18
53. Beneteau-Burnat B, Baudin B. Angiotensin converting enzyme: clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci 1991;18(6):702-705
54. Baarsma GS, La Hey E, Glasius E, et al. The predictive value of serum angiotensin converting enzyme and lysozyme levels in the diagnosis of ocular sarcoidosis. Am J Ophthalmol 1987;104:211-217
55. Weinreb RN, Sandman R, Ryder MI, et al. Angiotensin converting enzyme activity in human aqueous humor. Arch Ophthalmol 1985;103:34-36
56. Sharma OP, Vita JB. Determination of angiotensin-converting enzyme activity in tears: a noninvasive test for evaluation of ocular sarcoidosis. Arch Ophthalmol 1983;101:559-561
57. Sulavik SB, Spencer RP, Weed DA, et al. Recognition of distinctive patterns of gallium-67 distribution in sarcoidosis. J Nucl Med 1990;31:1909-1914
58. Karma A, Poukkula AA, Ruokonen AO. Assessment of activity of ocular sarcoidosis by gallium scanning. Br J Ophthalmol 1987;71:361-367
59. Weinreb RN, Tessler H. Laboratory diagnosis of ophthalmic sarcoidosis. Surv Ophthalmol 1984;28:653-664
60. Nessan VJ, Jacoway JR. Biopsy of minor salivary glands in the diagnosis of sarcoidosis. N Engl J Med 1979;301:922-924
61. Line BR, Hunninghake GW, Keogh BA, et al. Gallium-67 scanning as an indicator of the activity of sarcoidosis. In: Fanberg GL, ed. Sarcoidosis and other granulomatous diseases of the lung. New York: Marcel Dekker, 1983:287
62. Wesley RE, Johnson DT, Gutow GS. Central retinal artery occlusion. Ophthalmic Surg 1987;18:123-125
63. Hill RA, Quang HN, Baerveldt G, et al. Trabeculectomy and Molteno implantation for glaucomas associated with uveitis. Ophthalmology 1993;100:903-908
64. Herschler J, Davis EB. Modified goniotomy for inflammatory glaucoma: histologic evidence for the mechanism of pressure reduction. Arch Ophthalmol 1980;98: 684-687
65. Kanski JJ, McAllister JA. Trabeculodialysis for inflammatory glaucoma in children and young adults. Ophthalmology 1985;92:927-930
66. William RD, Hoskins HD, Shaffer RN. Outcome of trabeculodialysis for inflammatory glaucoma: a review of 25 cases. Invest Ophthalmol Vis Sci 1991;32:742
67. Jones E, Callen JP. Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas. J Am Acad Dermatol 1990;23:487-488
68. Morse SI, Cohn ZA, Hirsch JG, et al. The treatment of sarcoidosis with chloroquine. Am J Med 1961;30:779-784
69. Lower EE, Baughman RP. The use of low-dose methotrexate in refractory sarcoidosis. Am J Med Sci 1990;299:153-157
70. Toews GB, Lynch JP III. Methotrexate in sarcoidosis. Am J Med Sci 1990;300: 33-36
71. Lacher MJ. Spontaneous remission of response to methotrexate in sarcoidosis. Ann Intern Med 1968;63:1247-1248
72. Soriano FG, Caramelli P, Nitrini R, et al. Neurosarcoidosis. Therapeutic success with methotrexate. Postgrad Med J 1990;66:142-143
73. Kataria YP. Chlorambucil in sarcoidosis. Chest 1980;78:36-43
74. Gelwan MJ, Kellen RI, Burde RM, et al. Sarcoidosis of the anterior visual pathway: successes and failures. J Neurol Neurosurg Psychiatry 1988;51:1473-1480
75. Thivolet J, Faure M, Nicolas JF, et al. Therapeutic use of TP5 (thymopoietin 32-36) in sarcoidosis of the skin. Clin Immunol Immunopathol 1983;26:350-360
76. Bejar JM, Kerby GR, Ziegler DK, et al. Treatment of central nervous system sarcoidosis with radiotherapy. Ann Neurol 1985;18:258-260
77. Grizzanti JN, Knapp AB, Schecter AJ, et al. Treatment of sarcoid meningitis with radiotherapy. Am J Med 1982;73:605-608